Evidence map›Paper›PMID 41150198›Full record

ReviewToxins2025

Properties and Pharmacology of Scorpion Toxins and Their Biotechnological Potential in Agriculture and Medicine.

Cháriston André Dal Belo, Stephen Hyslop, Célia Regina Carlini

Abstract readReview
In one paragraph

Review in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cháriston André Dal BeloDepartamento Multidisciplinar, Escola Paulista de Política, Economia e Negócios (EPPEN), Universidade Federal de São Paulo (UNIFESP), Rua General Newton Estilac Leal, 932, Quitaúna, Osasco 06190-170, SP, Brazil.
Stephen HyslopDepartamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), Rua Vital Brazil, 80, Cidade Universitária Zeferino Vaz, Campinas 13083-888, SP, Brazil.
Célia Regina CarliniPrograma de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite 245, Porto Alegre 90050-170, RS, Brazil.ORCID 0000-0002-7027-2445

Funding

CAPES PDPG 3,4 (2023) CAPES PDPG 3,4 (2023)Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq Universal grant no. 405810/2023-7Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) Pesquisador Gaúcho grant no. 21/2551-0001946-8INCT INOVATox (CNPq) grant no. 406816/2022-0Instituto Nacional de Ciência e Tecnologia para Doenças Cerebrais, Excitotoxicidade e Neuroproteção (INCT-EN) CNPq grant no. 465671/2014-4; FAPERGS 17/2551-0000516-3Research fellowships from CNPq grant nos. 305933/2024-8, 305081/2019-5 and 312901/2022-4
6 · The paper itself

Abstract

Scorpion venoms contain a wide range of toxins that interact with a variety of target molecules (ion channels, receptors and enzymes) associated with synaptic transmission, action potential propagation, cardiac function, hemostasis and other physiological systems. Scorpion toxins are also active towards bacteria, viruses, fungi and parasites. Such interactions make scorpion toxins useful lead molecules for developing compounds with biotechnological and therapeutic applications, and as tools for cell biology. In addition, scorpion toxins act as insectotoxins, with promising applications as insecticides. This review describes the range of scorpion toxins and discusses their usefulness for the development of insecticides and therapeutic drugs.

Indexed as

Scorpion VenomsAgricultureAnimalsBiotechnologyHumansInsecticidesScorpionsInsecticidesScorpion Venomsinsecticidesion channelsneurotoxinspeptidesscorpion toxinstherapeutic applications

Identifiers

PMID41150198
PMCPMC12567881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.